T&CT LIMITED
Other human health activities
T&CT LIMITED
Other human health activities
Contact & Details
Contact
Registered Address
Suite 2.33 St John’S Innovation Centre Cowley Road Cambridge CB4 0WS United Kingdom
Full company profile for T&CT LIMITED (15948543), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 10 Sept 2024. Other human health activities. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Financial History
Revenue, profit, EBITDA and key financial figures
No Financial Data Available
Financial information will appear here once available.
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Alexander John Scott-barrett | Director | British | United Kingdom | 10 Sept 2024 | Active |
| Antony Rabar | Director | British | England | 10 Sept 2024 | Active |
| Daniel James Albershardt | Director | American | United States | 4 Feb 2025 | Active |
Persons with Significant Control
Persons with Significant Control (1)
Antony Rabar
British
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 14 Apr 2026 | Miscellaneous | Replacement filing of SH01 - 05/08/25 Statement of Capital gbp 79647.53 | |
| 14 Apr 2026 | Capital | Capital Return Purchase Own Shares | |
| 14 Apr 2026 | Miscellaneous | Replacement filing of SH01 - 30/07/25 Statement of Capital gbp 79291.74 | |
| 14 Apr 2026 | Miscellaneous | Replacement filing of SH01 - 10/06/25 Statement of Capital gbp 79220.93 | |
| 25 Mar 2026 | Capital | Allotment of shares (GBP 79,956.3) on 18 Sept 2025 |
Replacement filing of SH01 - 05/08/25 Statement of Capital gbp 79647.53
Capital Return Purchase Own Shares
Replacement filing of SH01 - 30/07/25 Statement of Capital gbp 79291.74
Replacement filing of SH01 - 10/06/25 Statement of Capital gbp 79220.93
Allotment of shares (GBP 79,956.3) on 18 Sept 2025
Recent Activity
Latest Activity
Replacement filing of SH01 - 05/08/25 Statement of Capital gbp 79647.53
2 weeks ago on 14 Apr 2026
Capital Return Purchase Own Shares
2 weeks ago on 14 Apr 2026
Replacement filing of SH01 - 30/07/25 Statement of Capital gbp 79291.74
2 weeks ago on 14 Apr 2026
Replacement filing of SH01 - 10/06/25 Statement of Capital gbp 79220.93
2 weeks ago on 14 Apr 2026
Allotment of shares (GBP 79,956.3) on 18 Sept 2025
1 months ago on 25 Mar 2026